Lantheus Holdings (LNTH) Long-Term Debt Repayments (2014 - 2026)
Lantheus Holdings (LNTH) reported Long-Term Debt Repayments of $216000.0 for Q1 2026, down 46.27% year-over-year from $402000.0 in Q1 2025, and down 38.81% quarter-over-quarter from $353000.0 in Q4 2025.
Lantheus Holdings (LNTH) Long-Term Debt Repayments (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Long-Term Debt Repayments data on file, last reported at $216000.0 in Q1 2026.
- Long-Term Debt Repayments for Q1 2026 came in at $216000.0, down 46.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $924000.0 (up 72.39% YoY), and the FY2025 annual result was $1.1 million, up 249.06% from the prior year.
- Long-Term Debt Repayments fell to $216000.0 in Q1 2026 per LNTH's latest filing, from $353000.0 in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $167.5 million in Q4 2022 and troughed at -$252000.0 in Q3 2024.
- A 5-year average of $10.5 million and a median of $292000.0 in 2025 frame the typical range for Long-Term Debt Repayments.
- The sharpest annual moves came in 2022 and 2024: Long-Term Debt Repayments surged 6364.45% in 2022, then slumped 281.25% in 2024.
- A 5-year view of Long-Term Debt Repayments shows it stood at $167.5 million in 2022, then tumbled by 99.98% to $32000.0 in 2023, then tumbled by 281.25% to -$58000.0 in 2024, then jumped by 708.62% to $353000.0 in 2025, then sank by 38.81% to $216000.0 in 2026.
- Business Quant data shows LNTH's Long-Term Debt Repayments at $216000.0 in Q1 2026, $353000.0 in Q4 2025, and $292000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 216,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 216,000.00 |
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Sep 30, 2025 | 292,000.00 |
| Sep 30, 2025 | 292,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Dec 31, 2024 | -58,000.00 |
| Dec 31, 2024 | -58,000.00 |
| Sep 30, 2024 | -252,000.00 |
| Sep 30, 2024 | -252,000.00 |
| Jun 30, 2024 | 444,000.00 |
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 184,000.00 |
| Mar 31, 2024 | 184,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |